Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-19T09:39:18.659Z Has data issue: false hasContentIssue false
  • English
  • Français

Thiamin deficiency and brain disorders

Published online by Cambridge University Press:  14 December 2007

Roger F. Butterworth
Roger F. Butterworth*
Affiliation:
Neuroscience Research Unit, Hôpital Saint-Luc (CHUM), 1058 St-Denis Street, Montreal, Quebec, Canada, H2X 3J4
*
Corresponding author: Dr Roger F. Butterworth, fax +1 514 412 7314, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Thiamin plays a key role in the maintenance of brain function. Thiamin diphosphate is cofactor for several enzymes involved in glucose metabolism whereas thiamin triphosphate has distinct properties at the neuronal membrane. Thiamin metabolism in the brain is compartmented between neurons and neighbouring glial cells. Thiamin deficiency is commonly encountered in severe malnutrition associated with chronic alcoholism, HIV–AIDS and gastrointestinal disease where it frequently results in Wernicke's encephalopathy (the Wernicke–Korsakoff syndrome). Wernicke's encephalopathy is severely underdiagnosed according to clinical criteria in both alcoholic and HIV–AIDS patients. Magnetic resonance imaging reveals bilateral ventricular enlargement, mammillary body atrophy and cerebellar degeneration indicative of selective neuronal loss that is characteristic of Wernicke's encephalopathy. Several mechanisms have been proposed to explain this selective loss of neurons including a cerebral energy deficit resulting from reductions in activity of thiamin diphosphate-dependent enzymes, oxidative stress and N-methyl-D-aspartate receptor-mediated excitotoxicity. Both microglia and perivascular endothelial cells are sources of NO and oxidative stress in thiamin deficiency. Decreased activities of thiamin diphosphate-dependent enzymes (in particular α-ketoglutarate dehydrogenase) have also been reported in neurodegenerative diseases such as Alzheimer's and Parkinson's diseases independent of patient malnutrition. In these cases, decreased activities result from direct toxic actions of oxidative stress and β-amyloid produced as part of the neuronal cell death cascade in these disorders.

Keywords

Thiamin deficiencyWernicke–Korsakoff syndromeAlcoholismAIDSNeuronal cell death
Type
Research Article
Information
Nutrition Research Reviews , Volume 16 , Issue 2 , December 2003 , pp. 277 - 284
Copyright
Copyright © The Author 2003

References

Aikawa, H, Watanabe, IS, Furuse, T, Iwasaki, Y, Satoyoshi, E, Sumi, T & Moroji, T (1984) Low energy levels in thiamine-deficient encephalopathy. Journal of Neuropathology and Experimental Neurology 43, 276–287.CrossRefGoogle ScholarPubMed
Albers, DS, Augood, SJ, Park, LC, Browne, SE, Martin, DM, Adamson, J, Hutton, M, Standaert, DG, Vonsattel, JP & Gibson, GE & Beal, MF (2000) Frontal lobe dysfunction in progressive supranuclear palsy: evidence for oxidative stress and mitochondrial impairment. Journal of Neurochemistry 74, 878–881.CrossRefGoogle ScholarPubMed
Bettendorff, L (1994) Thiamine in excitable tissues: reflections on a non-cofactor role. Metabolic Brain Disease 9, 183–210.CrossRefGoogle ScholarPubMed
Bettendorff, L, Sluse, F, Goessens, G, Wins, P & Grisar, T (1995) Thiamine deficiency-induced partial necrosis and mitochondrial uncoupling in neuroblastoma cells are rapidly reversed by addition of thiamine. Journal of Neurochemistry 65, 2178–2184.CrossRefGoogle ScholarPubMed
Butterworth, RF (2001) Maternal thiamine deficiency: still a problem in some world communities. American Journal of Clinical Nutrition 74, 712–713.CrossRefGoogle Scholar
Butterworth, RF & Besnard, AM (1990) Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease. Metabolic Brain Disease 5, 179–184.CrossRefGoogle ScholarPubMed
Butterworth, RF, Gaudreau, C, Vincelette, J, Bourgault, AM, Lamothe, F & Nutini, AM (1991) Thiamine deficiency and Wernicke's encephalopathy in AIDS. Metabolic Brain Disease 6, 207–212.CrossRefGoogle ScholarPubMed
Butterworth, RF & Héroux, M (1989) Effect of pyrithiamine treatment and subsequent thiamine rehabilitation on regional cerebral amino acids and thiamine-dependent enzymes. Journal of Neurochemistry 52, 1079–1084.CrossRefGoogle ScholarPubMed
Butterworth, RF, Kril, JJ & Harper, CG (1993) Thiamine-dependent enzyme changes in the brains of alcoholics: relationship to the Wernicke-Korsakoff syndrome. Alcoholism, Clinical and Experimental Research 17, 1084–1088.CrossRefGoogle Scholar
Calingasan, NY, Gandy, SE, Baker, H, Sheu, KFR, Kim, KS, Wisniewski, HM & Gibson, GE (1995) Accumulation of amyloid precursor protein-like immunoreactivity in rat brain in response to thiamine deficiency. Brain Research 677, 50–60.CrossRefGoogle ScholarPubMed
Calingasan, NY, Park, LCH, Calo, LL, Trifiletti, RR, Gandy, SE & Gibson, GE (1998) Induction of nitric oxide synthase and microglial responses precede selective cell death induced by chronic impairment of oxidative metabolism. American Journal of Pathology 153, 599–610.CrossRefGoogle ScholarPubMed
Casley, CS, Canevari, L, Land, JM, Clark, JB & Sharpe, MA (2002) ß-Amyloid inhibits integrated mitochondrial respiration and key enzyme activities. Journal of Neurochemistry 80, 91–100.CrossRefGoogle Scholar
Charness, ME & DeLaPaz, RL (1987) Mamillary body atrophy in Wernicke's encephalopathy: antemortem identification using magnetic resonance imaging. Annals of Neurology 22, 595–600.CrossRefGoogle ScholarPubMed
Cooper, JR & Pincus, JH (1979) The role of thiamine in nervous tissue. Neurochemistry Research 4, 223–239.CrossRefGoogle ScholarPubMed
Cullen, KM & Halliday, GM (1995) Neurofibrillary tangles in chronic alcoholics. Neuropathology and Applied Neurobiology 21, 312–318.CrossRefGoogle ScholarPubMed
Gautam, M, Noakes, PG, Mudd, J, Nichol, M, Chu, GC, Sanes, JR & Merlie, JP (1995) Failure of postsynaptic specialisation to develop at neuromuscular junctions of rapsyn-deficient mice. Nature 377, 232–236.CrossRefGoogle ScholarPubMed
Gibson, GE, Sheu, KF, Blass, JP, Baker, A, Carlson, KC, Harding, B & Perrino, P (1988) Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Archives of Neurology 45, 836–840.CrossRefGoogle ScholarPubMed
Gibson, GE & Zhang, H (2002) Interactions of oxidative stress with thiamine homeostasis promote neurodegeneration. Neurochemistry International 40, 493–504.CrossRefGoogle ScholarPubMed
Hakim, AM (1984) The induction and the reversibility of cerebral acidosis in thiamine deficiency. Annals of Neurology 16, 673–679.CrossRefGoogle ScholarPubMed
Harper, CG (1979) The incidence of Wernicke's encephalopathy in Australia. A neuropathological study of 131 cases. Journal of Neurology, Neurosurgery and Psychiatry 46, 593–598.CrossRefGoogle Scholar
Hazell, AS, Rama Rao, KV, Danbolt, NC, Pow, DV & Butterworth, RF (2001) Selective down-regulation of the astrocyte glutamate transporters GLT-1 and GLAST within the medial thalamus in experimental Wernicke's encephalopathy. Journal of Neurochemistry 78, 560–568.CrossRefGoogle ScholarPubMed
Héroux, M, Raghavendra Rao, VL, Lavoie, J, Richardson, JS & Butterworth, RF (1996) Alterations of thiamine phosphorylation and of thiamine-dependent enzymes in Alzheimer's disease. Metabolic Brain Disease 11, 81–88.CrossRefGoogle ScholarPubMed
Humphries, KM & Szweda, LI (1998) Selective inactivation of alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase: reaction of lipoic acid with 4-hydroxy-2-nonenal. Biochemistry 37, 15835–15841.CrossRefGoogle ScholarPubMed
Laforenza, U, Patrini, C & Rindi, G (1988) Distribution of thiamine, thiamine phosphates, and thiamine metabolizing enzymes in neuronal and glial cell enriched fractions of rat brain. Journal of Neurochemistry 51, 730–735.CrossRefGoogle ScholarPubMed
Langlais, PJ, Anderson, G, Guo, SX & Bondy, SC (1997) Increased cerebral free radical production during thiamine deficiency. Metabolic Brain Disease 12, 137–143.CrossRefGoogle ScholarPubMed
Langlais, PJ & Mair, MG (1990) Protective effects of the glutamate antagonist MK-801 on pyrithiamine-induced lesions and amino acid changes in rat brain. Journal of Neuroscience 10, 1664–1674.CrossRefGoogle ScholarPubMed
Matsushima, K, MacManus, JP & Hakim, AM (1997) Apoptosis is restricted to the thalamus in thiamine-deficient rats. Neuroreport 8, 867–870.Google Scholar
Mizuno, Y, Matuda, S, Yoshino, H, Mori, H, Hattori, N & Ikebe, S (1994) An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease. Annals of Neurology 35, 204–210.CrossRefGoogle Scholar
Pannunzio, P, Hazell, AS, Pannunzio, M, Rama Rao, KV & Butterworth, RF (2000) Thiamine deficiency results in metabolic acidosis and energy failure in cerebellar granule cells: an in vitro model for the study of cell death mechanisms in Wernicke's encephalopathy. Journal of Neuroscience Research 62, 286–292.3.0.CO;2-0>CrossRefGoogle Scholar
Park, LC, Zhang, H, Sheu, KF, Calingasan, NY, Kristal, BS, Lindsay, JG & Gibson, GE (1999) Metabolic impairment induces oxidative stress, compromises inflammatory responses, and inactivates a key mitochondrial enzyme in microglia. Journal of Neurochemistry 72, 1948–1958.CrossRefGoogle ScholarPubMed
Parker, WD Jr, Haas, R, Stumpf, DA, Parks, J, Eguren, LA & Jackson, C (1984) Brain mitochondrial metabolism in experimental thiamine de.ciency. Neurology 34, 1477–1481.CrossRefGoogle Scholar
Peters, RA (1936) The biochemical lesion in vitamin B1 deficiency. Application of modern biochemical analysis in its diagnosis. Lancet i, 1161–1164.CrossRefGoogle Scholar
Rao, VL, Richardson, JS & Butterworth, RF (1993) Decreased activities of thiamine diphosphatase in frontal and temporal cortex in Alzheimer's disease. Brain Research 631, 334–336.CrossRefGoogle ScholarPubMed
Todd, KG & Butterworth, RF (1998a) Increased neuronal cell survival after L-Deprenyl treatment in experimental thiamine deficiency. Journal of Neuroscience Research 52, 240–246.3.0.CO;2-B>CrossRefGoogle ScholarPubMed
Todd, KG & Butterworth, RF (1998b) Evaluation of the role of NMDA-mediated excitotoxicity in the selective neuronal loss in experimental Wernicke encephalopathy. Experimental Neurology 149, 130–138.CrossRefGoogle ScholarPubMed
Todd, KG & Butterworth, RF (1999) Early microglial response in experimental thiamine deficiency: an immunohistochemical analysis. Glia 25, 190–198.3.0.CO;2-B>CrossRefGoogle ScholarPubMed
Torvik, A (1985) Two types of brain lesions in Wernicke's encephalopathy. Neuropathology and Applied Neurobiology 11, 179–190.CrossRefGoogle ScholarPubMed
Trotti, D, Danbolt, NC & Volterra, A (1998) Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? Trends in Pharmaceutical Science 19, 328–334.CrossRefGoogle ScholarPubMed
Zimatkina, TI, Chernikevich, IP, Zimatkin, SM & Deitrich, RA (2000) Thiamin status in liver and brain of rats genetically selected for different sensitivity to hypnotic effect of alcohol. Alcoholism, Clinical and Experimental Research 24, 1620–1624.CrossRefGoogle ScholarPubMed